Skip to main content
Surgical Case Reports
Fig. 5 | Surgical Case Reports

Fig. 5

From: Selpercatinib for treating recurrent mixed medullary and follicular cell-derived thyroid carcinoma: a case report

Fig. 5

Computed tomography (CT) scans before and after selpercatinib treatment. CT scans at 11 months postoperatively revealed recurrence of mixed medullary and follicular cell-derived thyroid carcinoma at the right cervical lymph nodes (a) and upper mediastinal lymph nodes (b). After 9 weeks of treatment with selpercatinib, the cervical (c) and mediastinal lymph nodes (d) showed a reduction in size

Back to article page